Manufacturer record
Boffin Biotech Pvt. Ltd: regulatory record
Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
3 batches manufactured by Boffin Biotech Pvt. Ltd (Himachal Pradesh) were declared Not of Standard Quality between May 2019 and December 2025. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Records by type
3 records linked to Boffin Biotech Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Ambroxol Hydrochloride, Terbutalline Sulphate, Guaiphenesin & Menthol Syrup(soltus TS) | BL-14Mfg 2025-06 · Exp 2027-05 | ContentOther | Drugs Testing Laboratory, Madurai-19State lab | Dec 2025 |
| Ambroxol Hydrochloride, Terbutaline Sulphate, Guaiphenesin and Menthol Syrup (AVTUS-TG SYRUP) | BL-36Mfg 2023-07 · Exp 2025-06 | Assay of MentholAssay | RDTL ChandigarhCDSCO lab | Feb 2024 |
| Loperamide Hydrochloride Tablets IP (LOPSOL TABLETS) | BT-391Mfg 2018-08 · Exp 2020-07 | DissolutionDissolution | RDTL ChandigarhState lab | May 2019 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.